Its hard to tell from your analysis but it appears you have mixed OIP and recoverable factors before taking the 10%, ie a double incidence of the recovery factor. Perhaps I am misunderstanding you.
Micam mentioned the 10% from the AGM which is consistent with the 11% that has previously appeared in their presentations. Solimar, perhaps overly enthusiastically show the 11% and an alternate 25% based on modern recovery methodology.
It will be interesting to see if there is an improvemnt on the 10% given Neons conservative approach pre testing.
NEN Price at posting:
43.0¢ Sentiment: LT Buy Disclosure: Held
